Parnax Lab [PARNAXLAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Parnax Lab Ltd. wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Parnax Lab Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Parnax Lab Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.43 | 73.73 | Parnax Lab Ltd. |
| Price-to-Book Ratio | 2.01 | 13.36 | Parnax Lab Ltd. |
| Debt-to-Equity Ratio | 76.46 | 27.04 | Gujarat Themis Biosyn Ltd. |
| PEG Ratio | 0.12 | -17.55 | Parnax Lab Ltd. |
| EV/EBITDA | 9.07 | 52.76 | Parnax Lab Ltd. |
| Profit Margin (TTM) | 5.49% | 29.99% | Gujarat Themis Biosyn Ltd. |
| Operating Margin (TTM) | 7.77% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 7.77% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 13.84% | 19.64% | Gujarat Themis Biosyn Ltd. |
| Return on Assets (TTM) | 6.07% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $137.24M | $-251.22M | Parnax Lab Ltd. |
| Dividend Yield | N/A | 0.17% | N/A |
| 1-Year Return | 31.91% | 31.69% | Parnax Lab Ltd. |
| Price-to-Sales Ratio (TTM) | 0.79 | 22.23 | Parnax Lab Ltd. |
| Enterprise Value | $2.50B | $36.09B | Gujarat Themis Biosyn Ltd. |
| EV/Revenue Ratio | 1.10 | 22.65 | Parnax Lab Ltd. |
| Gross Profit Margin (TTM) | 40.69% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $198 | $15 | Parnax Lab Ltd. |
| Earnings per Share (Diluted) | $10.90 | $4.40 | Parnax Lab Ltd. |
| Beta (Stock Volatility) | 0.01 | -0.17 | Gujarat Themis Biosyn Ltd. |
Parnax Lab Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Parnax Lab Ltd. | 3.49% | -17.74% | -24.75% | -4.21% | 3.00% | -6.06% |
| Gujarat Themis Biosyn Ltd. | 1.72% | 7.42% | 6.10% | 33.40% | -1.19% | -10.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Parnax Lab Ltd. | 31.91% | 128.43% | 395.49% | 362.62% | 35.18% | 1,601.79% |
| Gujarat Themis Biosyn Ltd. | 31.69% | 84.69% | 84.69% | 84.69% | 84.69% | 84.69% |
Performance & Financial Health Analysis: Parnax Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | PARNAXLAB | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.81B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 7,666 | 79,452 |
| 90 Day Avg. Volume | 6,228 | 106,446 |
| Last Close | ₹126.00 | ₹401.80 |
| 52 Week Range | ₹96.25 - ₹182.00 | ₹225.05 - ₹479.00 |
| % from 52W High | -30.77% | -16.12% |
| All-Time High | ₹193.50 (Nov 04, 2024) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -34.88% | -16.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.57% | 0.10% |
| Quarterly Earnings Growth | 1.24% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.30% |
| Operating Margin (TTM) | 0.08% | 0.40% |
| Return on Equity (TTM) | 0.14% | 0.20% |
| Debt to Equity (MRQ) | 76.46 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹78.10 | ₹24.29 |
| Cash per Share (MRQ) | ₹1.79 | ₹0.92 |
| Operating Cash Flow (TTM) | ₹297.41M | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹115.19M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.17% |
| Last 12-Month Dividend | N/A | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Parnax Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | PARNAXLAB (Apr 24, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.43 | 73.73 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.12 | -17.55 |
| Price to Sales (TTM) | 0.79 | 22.23 |
| Price to Book (MRQ) | 2.01 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹1.81B | ₹35.41B |
| Enterprise Value | ₹2.50B | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.10 | 22.65 |
| Enterprise to EBITDA | 9.07 | 52.76 |
| Risk & Other Metrics | ||
| Beta | 0.01 | -0.17 |
| Book Value per Share (MRQ) | ₹78.10 | ₹24.29 |
Financial Statements Comparison: Parnax Lab Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PARNAXLAB (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 1.88B | 1.51B |
| Cost of Goods Sold | 1.25B | 318.78M |
| COGS % of Revenue | 66.6% | 21.1% |
| Gross Profit | 627.22M | 1.19B |
| Gross Margin | 33.4% | 78.9% |
| Research & Development | 17.49M | 34.37M |
| Operating Income (EBIT) | 197.88M | 642.49M |
| Operating Margin | 10.5% | 42.6% |
| EBITDA | 285.44M | 713.04M |
| EBITDA Margin | 15.2% | 47.3% |
| Pre-Tax Income | 156.74M | 655.38M |
| Pre-Tax Income % of Revenue | 8.3% | 43.5% |
| Income Tax | 41.35M | 167.66M |
| Income Tax % of Revenue | 2.2% | 11.1% |
| Net Income (Profit) | 115.39M | 487.72M |
| Profit Margin | 6.1% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | PARNAXLAB (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 5.50M | 116.94M |
| Total Current Assets | 683.40M | 519.73M |
| Total Current Assets % of Revenue | 36.4% | 34.5% |
| Total Current Liabilities | 743.34M | 205.60M |
| Total Current Liabilities % of Revenue | 39.6% | 13.6% |
| Long-Term Debt | 262.42M | 296.36M |
| Long-Term Debt % of Revenue | 14.0% | 19.7% |
| Total Shareholders Equity | 832.42M | 2.48B |
| Retained Earnings | 554.20M | 2.37B |
| Retained Earnings % of Revenue | 29.5% | 157.4% |
| Property, Plant & Equipment | 292.67M | 411.30M |
Cash Flow Statement Comparison
| Metric | PARNAXLAB (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | 297.41M | 970.68M |
| Operating Cash Flow % of Revenue | 15.8% | 64.4% |
| Capital Expenditures | -70.38M | -1.16B |
| Free Cash Flow | 137.24M | -251.22M |
| FCF Margin | 7.3% | -16.7% |
| Debt Repayment | -104.25M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PARNAXLAB | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 11.49M | 108.97M |
| Float Shares | 2.99M | 29.52M |
| % Held by Insiders | 73.92% | 71.98% |
| % Held by Institutions | 0.00% | 1.18% |
| % Held by Public | 26.08% | 26.84% |
Dividend Analysis & Yield Comparison: Parnax Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | PARNAXLAB | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.67 |
| Last 12-Month Dividend Yield | N/A | 0.17% |
| 3-Year Avg Annual Dividend | N/A | ₹0.22 |
| 3-Year Avg Dividend Yield | N/A | 0.17% |
| 3-Year Total Dividends | N/A | ₹0.67 |
| Ex-Dividend Date | N/A | Sep 04, 2025 |